New Zealand markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
113.24+0.80 (+0.71%)
At close: 04:03PM EDT
112.80 -0.44 (-0.39%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 197.40B
Enterprise value 206.33B
Trailing P/E 26.16
Forward P/E 23.26
PEG ratio (5-yr expected) 6.82
Price/sales (ttm)4.52
Price/book (mrq)5.58
Enterprise value/revenue 4.64
Enterprise value/EBITDA 15.87

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-3.45%
S&P500 52-week change 3-7.05%
52-week high 3142.60
52-week low 3104.63
50-day moving average 3116.79
200-day moving average 3124.03

Share statistics

Avg vol (3-month) 35.59M
Avg vol (10-day) 36.84M
Shares outstanding 51.75B
Implied shares outstanding 6N/A
Float 81.74B
% held by insiders 10.74%
% held by institutions 175.38%
Shares short (28 Apr 2022) 413.46M
Short ratio (28 Apr 2022) 42.65
Short % of float (28 Apr 2022) 40.79%
Short % of shares outstanding (28 Apr 2022) 40.77%
Shares short (prior month 30 Mar 2022) 412.1M

Dividends & splits

Forward annual dividend rate 41.88
Forward annual dividend yield 41.66%
Trailing annual dividend rate 31.84
Trailing annual dividend yield 31.64%
5-year average dividend yield 41.57
Payout ratio 442.23%
Dividend date 315 May 2022
Ex-dividend date 412 Apr 2022
Last split factor 210000:4798
Last split date 301 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 17.35%
Operating margin (ttm)22.58%

Management effectiveness

Return on assets (ttm)8.56%
Return on equity (ttm)22.26%

Income statement

Revenue (ttm)44.51B
Revenue per share (ttm)25.13
Quarterly revenue growth (yoy)13.80%
Gross profit (ttm)25.01B
EBITDA 13.48B
Net income avi to common (ttm)7.7B
Diluted EPS (ttm)4.31
Quarterly earnings growth (yoy)36.50%

Balance sheet

Total cash (mrq)8.16B
Total cash per share (mrq)4.66
Total debt (mrq)17.12B
Total debt/equity (mrq)48.06
Current ratio (mrq)1.85
Book value per share (mrq)20.22

Cash flow statement

Operating cash flow (ttm)9.96B
Levered free cash flow (ttm)7.54B